Adelphi Research

Looking forward to meeting people interested in cultivating their career with us!

Looking for a quick recap on European Society for Medical Oncology (ESMO) 2024? See below for a summary of key data and takeaways! You can also access this information via our blog: https://lnkd.in/ejmazWDQ #ESMO24 #Oncology #AdelphiResearch #MarketResearch

Some really interesting thoughts from Adelphi Research’s DEI certified co-lead, Claire Mottershead, on her key take homes from the EPHMRA Chapter Meeting in Basel last week.    Have a read and get in touch with us at contactAR@adelphigroup.com if you are interested to hear more.

And the results are in! #EASD2024 was held in Madrid between 9-13th September. Our self-funded post-conference survey revealed some fascinating results! Eli Lilly and Novo Nordisk were the big players this year, driven by the buzz around Mounjaro and semaglutide brands (Ozempic, Wegovy, Rybelsus). Want to learn more? Check out our blog for a post on hot topics at EASD 2024 here: https://lnkd.in/eAsgCGCr Contact our team for more information at contactAR@adelphigroup.com

We are looking forward to hearing Claire’s highlights of the EPHMRA Basel Chapter Meeting, and how this will help shape the insights we provide to our clients.    This topic continues to grow in importance and Adelphi have supported both Claire Mottershead and our colleague Emily Sumners in achieving Level 4 from the Chartered Management Institute in Promoting Equality, Diversity and Inclusion in our business and work with our clients. Get in touch with us at contactAR@adelphigroup.com

ESMO - European Society for Medical Oncology – is 2 days away and we are eager to see the latest discussions, workshops and data releases taking place in the oncology community. Follow Adelphi Research to see our take on the #ESMO24 key takeaways after the conference!    What are you most looking forward to at #ESMO24? Comment below!

EASD starts next week and we can’t wait to see the results from our self-funded post-EASD survey conducted with HCPs attending the conference.   We’ll explore… - Which sessions had the highest engagement - Which therapies generated the most interest - The top three products and companies HCPs were most excited about. Follow us to find out the results! #diabetes #innovation #EASD2024

Adelphi Research is committed to creating and maintaining a working environment where every colleague has a sense of belonging regardless of sex, gender identity or expression, race, ethnicity, religion, age, health, ability, or sexual orientation.   We support our mission through ongoing initiatives, research, and trainings designed to facilitate diversity, equity, and inclusivity within our team and in the research we conduct for our clients. This includes funding members of the team to complete a Chartered Management Institute Level 4 Award in Promoting Equality, Diversity and Inclusion. The expertise gained from this qualification informs our approach towards team/project management and study recruitment techniques. To find out more, or to ask us any questions on this topic, please reach out to ContactAR@adelphigroup.com. 

Did you know July is UV Awareness Month? With summer holidays abound, check out the tips below from the American Academy of Dermatology to stay safe while enjoying the sun and protect against skin cancer.   #UVAwarenessMonth #skincancer #AAD

The Adelphi Research team in the UK attended #Nudgestock2024 in London last week, and took loads of inspiration away from all the fascinating talks. The theme this year was all about TIME. The benefits of taking a moment to slow down…deliberate, reflect and work through the “messy”, in a world that is constantly increasing its pace. Read below for our favourite quotes from the day, encouraging us to think differently and consider how we spend our time!